Griscelli syndrome

Griscelli syndrome
OMIM	214450 607624 609227
DiseasesDB	32776 Template:DiseasesDB2
eMedicine	derm/926

WikiDoc Resources for Griscelli syndrome
Articles
Most recent articles on Griscelli syndrome Most cited articles on Griscelli syndrome Review articles on Griscelli syndrome Articles on Griscelli syndrome in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Griscelli syndrome Images of Griscelli syndrome Photos of Griscelli syndrome Podcasts & MP3s on Griscelli syndrome Videos on Griscelli syndrome
Evidence Based Medicine
Cochrane Collaboration on Griscelli syndrome Bandolier on Griscelli syndrome TRIP on Griscelli syndrome
Clinical Trials
Ongoing Trials on Griscelli syndrome at Clinical Trials.gov Trial results on Griscelli syndrome Clinical Trials on Griscelli syndrome at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Griscelli syndrome NICE Guidance on Griscelli syndrome NHS PRODIGY Guidance FDA on Griscelli syndrome CDC on Griscelli syndrome
Books
Books on Griscelli syndrome
News
Griscelli syndrome in the news Be alerted to news on Griscelli syndrome News trends on Griscelli syndrome
Commentary
Blogs on Griscelli syndrome
Definitions
Definitions of Griscelli syndrome
Patient Resources / Community
Patient resources on Griscelli syndrome Discussion groups on Griscelli syndrome Patient Handouts on Griscelli syndrome Directions to Hospitals Treating Griscelli syndrome Risk calculators and risk factors for Griscelli syndrome
Healthcare Provider Resources
Symptoms of Griscelli syndrome Causes & Risk Factors for Griscelli syndrome Diagnostic studies for Griscelli syndrome Treatment of Griscelli syndrome
Continuing Medical Education (CME)
CME Programs on Griscelli syndrome
International
Griscelli syndrome en Espanol Griscelli syndrome en Francais
Business
Griscelli syndrome in the Marketplace Patents on Griscelli syndrome
Experimental / Informatics
List of terms related to Griscelli syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Griscelli syndrome is a rare autosomal childhood disorder characterised by albinism (hypopigmentation).

Types

• Type I Griscelli syndrome -- MYO5A
• Type II Griscelli syndrome is caused by the knock out of the gene for Rab27A and is characterised by hypopigmentation and immunodeficiency. Children with this syndrome die with a mean age of 5 years. The only cure is bone-marrow transplantation. To date approximately 10 children have received successful bone marrow transplants for type II Griscelli syndrome.
• Type III Griscelli syndrome -- melanophilin, MYO5A

Presentation

Griscelli syndrome is defined by the characteristic hypopigmentation. This may be caused by the loss of three different genes, each of which has different additional effects, resulting in the three types of syndrome.

Pathophysiology

In melanocytes, melanosomes (vesicles containing the pigment melanin) are transported on microtubules. They are then bound by Rab27A which recruits Slac2-a and myosin Va. This complex then transfers the melanosomes from the microtubules to actin filaments. This transfer is necessary for the transport of melanosomes from the perinuclear area to the cell periphery. The loss of any one of these proteins interrupts melanosome transport and results in the hypopigmentation.

However, these three proteins do not work together in other cells and Rab27A effectors may be 'mix and match' For example the knockout of Rab27 causes the hypopigmentation but also immunodeficiency due to deficiencies in cytotoxic killing activity in cytotoxic T cells (something that also depends on vesicle transport). While, the knockout of myosin Va does not cause immunodeficiency, but it does cause neural defects. Though some neural problems (i.e brain damage) can be seen in Rab27A deficient children, this is thought to be a secondary effect of the immune problems, and not directly due to the lack of Rab27A.

Eponym

It is named for Claude Griscelli.